VE-821
Product Specifications
Background
VE-821 is a potent and selective ATP-competitive ATR (Ataxia-telangiectasia and Rad3-related protein) inhibitor, Ki=13 nM.1 Increases the sensitivity of pancreatic2 and ovarian3 cancer cells to radiation and chemotherapy. Increased replication stress induced by PARP inhibitors or chemotherapeutic agents increases sensitivity to VE-821 in neuroblastoma cells.4 Enhances the cytotoxicity of DNA damaging agents.5
Conjugation
Unconjugated
Buffer
Beige solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6427461-01 0.1 mL
MSH2 (MutS Homolog 2, Mismatch Repair Protein 2, Familial Nonpolyposis Colon Cancer Type 1, COCA1, FCC1, HNPCC, HNPCC1, LCFS2) (MaxLight 650)
Sign In for Pricing
View Details MBS6427461-02 5x 0.1 mL
MSH2 (MutS Homolog 2, Mismatch Repair Protein 2, Familial Nonpolyposis Colon Cancer Type 1, COCA1, FCC1, HNPCC, HNPCC1, LCFS2) (MaxLight 650)
Sign In for Pricing
View Details 
MBS1475410-01 0.02 mg (E-Coli)
Recombinant Bordetella parapertussis Transaldolase (tal)
Sign In for Pricing
View Details